- Home
- OBE vs PRTC Comparison
OBE vs PRTC Comparison
Compare OBE & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBE
- PRTC
- Stock Information
- Founded
- OBE 1979
- PRTC 2015
- Country
- OBE Canada
- PRTC United States
- Employees
- OBE N/A
- PRTC N/A
- Industry
- OBE Oil & Gas Production
- PRTC Biotechnology: Pharmaceutical Preparations
- Sector
- OBE Energy
- PRTC Health Care
- Exchange
- OBE Nasdaq
- PRTC Nasdaq
- Market Cap
- OBE N/A
- PRTC 431.1M
- IPO Year
- OBE N/A
- PRTC N/A
- Fundamental
- Price
- OBE $5.87
- PRTC $19.34
- Analyst Decision
- OBE Strong Buy
- PRTC Buy
- Analyst Count
- OBE 1
- PRTC 1
- Target Price
- OBE $14.00
- PRTC $45.00
- AVG Volume (30 Days)
- OBE 444.8K
- PRTC 2.1K
- Earning Date
- OBE 05-01-2025
- PRTC 04-24-2025
- Dividend Yield
- OBE N/A
- PRTC N/A
- EPS Growth
- OBE N/A
- PRTC N/A
- EPS
- OBE N/A
- PRTC N/A
- Revenue
- OBE $508,187,151.00
- PRTC $468,000.00
- Revenue This Year
- OBE $11.82
- PRTC N/A
- Revenue Next Year
- OBE $24.27
- PRTC $160.00
- P/E Ratio
- OBE N/A
- PRTC N/A
- Revenue Growth
- OBE 11.92
- PRTC N/A
- 52 Week Low
- OBE $4.74
- PRTC $16.30
- 52 Week High
- OBE $9.07
- PRTC $34.00
- Technical
- Relative Strength Index (RSI)
- OBE 58.89
- PRTC 63.07
- Support Level
- OBE $5.83
- PRTC $16.30
- Resistance Level
- OBE $6.22
- PRTC $18.34
- Average True Range (ATR)
- OBE 0.23
- PRTC 0.34
- MACD
- OBE 0.07
- PRTC 0.16
- Stochastic Oscillator
- OBE 71.77
- PRTC 99.35
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.